Clinical study
Peroxisome Proliferator-Activated Receptor- Is a Potent Target for Prevention and Treatment in Human Prostate and Testicular Cancer
Table 1
Statistical analysis of PPAR-, -, and - immunostaining.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Graded 0–4 on the coded sections by two blind observers. 0, no staining; 4+, maximum intensity. Statistical analysis was performed using the ANOVA (-value). PPAR- and - immunostaining were significantly intense in all cases. There were no differnces among PC, PIN, BPH and NP. PPAR- immunostainings of tumor were significantly more extensive and intense in PC and in PIN than in tissue of BPH or NP. PPAR- staining was high in blood vessels and stromal tissues of PC and PIN, with no significant difference between them. However, the expressions of the PPAR- in the blood vessels and stromal tissues from BPH and NP were at the basic level. (*). |